中國南方航空股份(01055.HK)更換中金公司為保薦機構
格隆匯12月27日丨中國南方航空股份(01055.HK)發佈公告,公司經中國證監會於2018年8月2日簽發的《關於核准中國南方航空股份有限公司非公開發行股票的批覆》(證監許可[2018]1235號)的核準,非公開發行1,578,073,089股A股並在上海證券交易所上市。公司聘請瑞銀證券,擔任2018年非公開發行及持續督導的保薦機構。2018年非公開發行的持續督導期至2019年12月31日。
根據相關規定,公司因再次申請發行證券另行聘請保薦機構的,應當終止與原保薦機構的保薦協議,另行聘請的保薦機構應當完成原保薦機構未完成的持續督導工作。因此,瑞銀證券未完成的持續督導工作,將由中金公司承接。中金公司指派王珏、龍海擔任保薦代表人,負責公司的持續督導相關工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.